Default company panoramic image
Logo

GMSBiotech, Inc.

GMSBiotech is a product company, with a patented technology to make genetics testing faster, easier to use and less costly to its customers.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Tucson, AZ, USA
  • Currency USD
  • Founded January 2001
  • Employees 12
  • Website gmsbiotech.com

Company Summary

GMSBiotech develops, manufactures and markets genetics testing products that are faster, easier to use, and less costly to its customers. Current genetics testing is complex, cumbersome, and costly, and require the test to be re-run due to ambiguities in the results. Our customers: hospitals, labs, and registries are looking for a better alternative, and with the healthcare industry facing more cost pressures, we have a solution that helps.

Team

  • Default avatar
    Krishna Jayaraman
    Dr.

    President, CEO & Co-Founder: Over 20 years of experience in the diagnostics, therapeutics and microarray industry. Previously, Dr. Jayaraman was founder and CEO, Gemini Biotech, Inc., a director of R&D at Motorola Biochip Systems, and Director of Chemistry at Triplex Pharmaceuticals. Dr. Jayaraman has extensive experience instituting GMP/GLP procedures and directing research in diagnostics at Eastman Kodak and Motorola.

  • Default avatar
    Mike Hogan
    Dr.

    Chief Scientific Officer, Co-Founder: An internationally recognized expert in the physical chemistry of applied genetics. Previously, Dr. Hogan was a founder of Triplex Pharmaceuticals, Genometrix and GenVault. Dr. Hogan held academic appointments at Princeton University and Baylor College of Medicine and Texas A&M and sits on several NIH panels in translational biology, companion diagnostics, and bio specimen science.

  • Default avatar
    Milan Patel
    Mr.

    Chief Financial Officer: Over 20 years of experience with numerous companies . Recently served as CFO of 2020 Company, LLC -a leading premier business and technology solutions company in the areas of health, education, and science. Mr. Patel has extensive experience in corporate finance, business strategy and planning, infrastructure and organizational development, and controls, compliance and audit.

  • Default avatar
    Benjamin Adler
    Dr.

    Vice President of Intellectual Property: Manages the legal affairs of gmsbiotech including responsibility for securing patent protection for gmsbiotech invention in the U.S., and rest of World. Dr. Adler holds a Ph.D. in molecular pharmacology and a law degree from Boston University School of Law.

  • Default avatar
    Alan Jernigan
    Mr.

    Senior Vice President - Sales & Marketing: Over 25 years of Sales & Marketing experience in vitro diagnostics experience. Recently was Chief Sales & Marketing Officer for One Lambda responsible for global HLA-Typing Sales & Marketing. Alan has worked for large companies such as Abbott & Roche as well as smaller start-ups. He has launched over 50 novel diagnostic products and helped 3 companies reach successful exits and return on investment for

  • Default avatar
    Krystylle Richardson
    Ms.

    Vice President of Quality Systems & Regulatory Affairs:
    Over 20 years of experience in medical device, development & regulatory affairs. Responsible for submission of FDA 510K applications. Experience in regulatory affairs and product development, including 510k registrations, PMA registrations, CE Marking, FDA audits, and ISO 9001 and 12485 certifications.

Advisors

  • Default avatar
    Geoff Ossias, Quarles & Brady LLP
    Lawyer
    Unconfirmed
    Default avatar
    T.V. Nathan CPA
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Illinois Technology Enterprise Council, State of Illinois
    Unconfirmed
    Default avatar
    QuantRx
    Unconfirmed
    Default avatar
    Series A, First Round Angel investors
    Unconfirmed